In November 2020, the patient developed thrombocytopenia (platelet level: 91×103/ul) with normal hemoglobin and normal white cell counts and received the interleukin-11(IL-11) therapy to enhance the proliferation of megalokaryocytes for 2 weeks. This evidence concerns the gene IL11 and Thrombocytopenia.